iRhythm Holdings, Inc. $IRTC reported second-quarter 2026 revenue of $224.2 million, up 20.1% from a year earlier and slightly above the $223.7 million analyst estimate. Gross profit rose to $163.2 million, also increasing 22.8% year over year.
The company remained near breakeven, posting an operating loss of $2.5 million and a net loss attributable to common shareholders of $381,000. Diluted earnings per share came in at -$0.01, compared with an estimate of -$0.0045.
Cash generation improved sharply, with operating cash flow rising to $51.1 million, up 84.7% from the prior year. Capital spending totaled $13.6 million, while cash and cash equivalents stood at $246.7 million. Total liabilities were $907.4 million.
- Revenue: $224.2 million, up 20.1%
- Gross profit: $163.2 million, up 22.8%
- Operating cash flow: $51.1 million, up 84.7%
- Net loss attributable to common shareholders: $381,000
- Shares rose 1.47% after the close
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
iRhythm Holdings, Inc. Insider Trading Activity
iRhythm Holdings, Inc. insiders have traded $IRTC stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $IRTC stock by insiders over the last 6 months:
- QUENTIN S. BLACKFORD (President and CEO) has made 0 purchases and 4 sales selling 39,353 shares for an estimated $5,232,772.
- CHAD PATTERSON (CHIEF COMM & PRODUCT OFFICER) has made 0 purchases and 3 sales selling 13,411 shares for an estimated $1,785,105.
- MINANG TURAKHIA (CHIEF MED/SCI OFCR EVP ADVTECH) has made 0 purchases and 5 sales selling 13,254 shares for an estimated $1,751,530.
- PATRICK MICHAEL MURPHY (CBO and CLO) has made 0 purchases and 4 sales selling 12,162 shares for an estimated $1,616,568.
- SUMI SHRISHRIMAL (EVP, Chief Risk Officer) has made 0 purchases and 4 sales selling 9,047 shares for an estimated $1,205,383.
- DANIEL G. WILSON (Chief Financial Officer) has made 0 purchases and 5 sales selling 8,583 shares for an estimated $1,138,629.
- MERVIN SMITH (EVP Strategic Business Ops) has made 0 purchases and 4 sales selling 6,125 shares for an estimated $824,026.
- MARC WADE ROSENBAUM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 5,893 shares for an estimated $793,874.
- ABHIJIT Y TALWALKAR has made 0 purchases and 4 sales selling 5,312 shares for an estimated $773,980.
- BRIAN LEE LAWRENCE (Chief Technology Officer) sold 1,014 shares for an estimated $122,491
- SEAN CLINTON FREEMAN (EVP, Strategy & Corp Devt) sold 918 shares for an estimated $114,483
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
iRhythm Holdings, Inc. Hedge Fund Activity
We have seen 142 institutional investors add shares of iRhythm Holdings, Inc. stock to their portfolio, and 159 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 781,638 shares (+94.6%) to their portfolio in Q1 2026, for an estimated $92,248,916
- FMR LLC added 733,153 shares (+116.6%) to their portfolio in Q1 2026, for an estimated $86,526,717
- CAPITAL RESEARCH GLOBAL INVESTORS removed 675,156 shares (-57.0%) from their portfolio in Q1 2026, for an estimated $79,681,911
- HOLOCENE ADVISORS, LP added 565,090 shares (+82.7%) to their portfolio in Q1 2026, for an estimated $66,691,921
- RTW INVESTMENTS, LP added 486,510 shares (+41.2%) to their portfolio in Q1 2026, for an estimated $57,417,910
- PRICE T ROWE ASSOCIATES INC /MD/ removed 466,433 shares (-92.9%) from their portfolio in Q1 2026, for an estimated $55,048,422
- POINT72 ASSET MANAGEMENT, L.P. added 379,937 shares (+173.1%) to their portfolio in Q1 2026, for an estimated $44,840,164
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
iRhythm Holdings, Inc. Analyst Ratings
Wall Street analysts have issued reports on $IRTC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/10/2026
- Needham issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for iRhythm Holdings, Inc., check out Quiver Quantitative's $IRTC forecast page.
iRhythm Holdings, Inc. Price Targets
Multiple analysts have issued price targets for $IRTC recently. We have seen 11 analysts offer price targets for $IRTC in the last 6 months, with a median target of $175.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $150.0 on 07/06/2026
- Marie Thibault from BTIG set a target price of $185.0 on 06/22/2026
- William Plovanic from Canaccord Genuity set a target price of $152.0 on 06/01/2026
- Stephanie Piazzola from B of A Securities set a target price of $180.0 on 05/18/2026
- Joanne Wuensch from Citigroup set a target price of $157.0 on 05/04/2026
- Allen Gong from JP Morgan set a target price of $175.0 on 05/01/2026
- Nathan Treybeck from Wells Fargo set a target price of $180.0 on 05/01/2026
